Navigation Links
MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Date:8/19/2007

MONMOUTH JUNCTION, N.J., Aug. 6 /PRNewswire/ -- MicroDose Technologies, Inc., a privately held drug delivery and specialty pharmaceuticals company, today announces top line results from a glucose clamp study of the QDose inhaled insulin product. MicroDose, through its joint venture with Vectura Group plc, QDose Limited, has developed a highly efficient, rapid acting, insulin inhaler, based upon MicroDose's proprietary electronic inhaler technology and Vectura's dry powder insulin formulation. The QDose inhaled insulin product offers dose titration capability over a broad range of dose strengths, in a single inhalation. The inhaler also provides active dose feedbacks to the patient in an easy to use, pocket-sized device.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070803/NYF045LOGO )

The study employed the widely used and validated glucose clamp technique, and results demonstrated that:

-- The inhaled insulin formulation was safe and effective

-- Peak levels of insulin activity were achieved more quickly following

the inhaled insulin than those from the subcutaneous insulin injection

-- Relative bioavailability of inhaled insulin was approximately 18%

during the 3 hour period following dosing; higher than the published

values for the currently marketed inhalation product

-- Administration of the same total dose of inhaled insulin from either a

single blister or two "half strength" blisters led to equivalent

activity; an advantage over the currently marketed inhalation product

The study was a randomized, crossover, open-label glucose clamp study, designed to confirm the high relative bioavailability of the QDose insulin formulation previously observed, and to demonstrate the product's dose titration capability. The results confirmed the faster onset of action seen with the QDose inhaled formu
'/>"/>

SOURCE MicroDose Technologies, Inc.

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...swire/ -- Access MediQuip, LLC, the nation,s first...dical device management solutions to the healthcar...its corporate headquarters to Lake Mary, Florida. ...growth, includes a major expansion of the Primera ...uary 2010 and relocation and expansion of the Hous...
(Date:11/9/2009)...tCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: IST...ompany,s Bepreve(TM) (bepotastine besilate ophthal...e results were presented in poster sessions at the...lergy, Asthma & Immunology (ACAAI) in Miami Be...Treatment of Ocular Itching with Bepotastine Besil...
(Date:11/9/2009)...wswire/ -- Thomson Reuters today announced the n...eading clinical surveillance solution that enables...me and respond immediately to improve clinical qua...s upgrade is available to current CareFocus custom...ontains several powerful enhancements that improve...
Breaking Medicine Technology:Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Proteins in gel 8982 1PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C F M Group 12767 1PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C F M Group 12767 2PHT Names VP to Lead Sales of A Claim Payment Solution for Doctors Hospitals 49924 1PHT Names VP to Lead Sales of A Claim Payment Solution for Doctors Hospitals 49924 2
...stent may hold clinical edge over Taxus stent at t..., March 31 Early results of the SPIRIT II study,s...Taxus stent in six-month,findings on angiography a...ow, a new analysis shows that after two years, the... may continue to hold a clinical edge over,its pac...
...any,s TAXUS(R) and PROMUS(TM) Stents demonstrate p...mes, NATICK, Mass. and CHICAGO, March 31 Boston,...d positive two-year results,from Abbott,s prospect...ty,SPIRIT II Trial comparing the safety and effica...ting Coronary Stent and Boston Scientific,s,worldw...
Other Medicine Technology:SPIRIT II Explores Long-Term Performance of XIENCE V Stent 2SPIRIT II Explores Long-Term Performance of XIENCE V Stent 3Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms 2Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms 3Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms 4
(Date:11/9/2009)...k (NCCN) has posted a draft white paper for public...rm comparative effectiveness clinical evaluations ...the NCCN Comparative Therapeutic Index(TM) (CTI), ...ersus-benefit of different treatment options recom... Oncology(TM). The paper will be posted for public...
(Date:11/9/2009)...-- For the third consecutive year, the Barbara Ann... preferred hospital for cancer care in southeast M...earch Corporation. ,, (Logo: http://www.news..., The annual survey was conducted through an email...009. Survey respondents were the primary healthcar...
(Date:11/9/2009)...e/ -- Speaker Nancy Pelosi released the following...ealth Care for America Act (H.R. 3962) that wi...Part D costs for people living with HIV/AIDS. H.R....0 to 215: ,, "Effective drug treatments have i...nds of Americans living with HIV/AIDS. However, ma...
(Date:11/9/2009)...rrent campaign finance system ,, WASHINGTON, N...ss who noted "no" on health care reform legislatio...ore in campaign donations from health insurance in...lation to overhaul of the nation,s health care sys... of campaign reform groups. ,, "The health care...
(Date:11/9/2009)..., , Montreal, November 9, 2009 On Noah,s Ark ani...s trillions of cells are coupled, too, and so are ...hese don,t come in twos, they are regrouped into i...ell networks are the backbone of life and illness... cell clusters down to their original pairs. , ...
Breaking Medicine News(10 mins):Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 2Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 3Health News:NCCN Posts Comparative Effectiveness White Paper for Public Comment 4Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:'No' Votes on Health Care Bill Received $2.3 Million More from Health Insurance Industry 2
... Eve , , ROCKVILLE, Md., Dec. 16 Some New Ye...or example, more people are likely to die in alcoh...on other mid-week winter evenings. , , (Photo...ministration statistics shows that, by the time ou...
...at the 27th Annual J.P. Morgan Healthcare Conferen...xecutive vice president, finance and chief,financi... company at noon,Central time. , A live audi... of the presentation will be available later that ...
...second Indiana Planned Parenthood clinic shows an ...rs evade their legal responsibility to report the ...the second video in Live Action Film,s "Mona Lisa ...undercover this summer at a Planned Parenthood in ...
...day the five grand prize winners of the 2008 WEIG... All five grand prize winners are living proof th...nges in other areas of life. Their Inspiring Stori...inner is featured on the cover of Good Housekeepi...
...nc., a subsidiary of SAP AG (NYSE: SAP ), today ...ted and implemented SAP(R) solutions to more,effec...healthcare system in,the areas of financials and p...rise applications to help achieving newly,establis...
...,the company,s Enterprise (formerly TouchWorks(R))...1 product in its market segment for the second yea.... In its closely watched 2008,Top 20 Best in KLAS...ng hospital market segment. , (Logo: http:/...
Other Medicine News:Health News:New Year, Old Myths, New Fatalities 2Health News:New Year, Old Myths, New Fatalities 3Health News:Abuse Pattern Develops as Second Indiana Planned Parenthood Covers Up Statutory Rape of 13-Year-Old 2Health News:Weight Watchers(R) Reveals the 2008 Inspiring Stories of the Year Contest Winners Online and in the January Issue of Good Housekeeping 2Health News:Weight Watchers(R) Reveals the 2008 Inspiring Stories of the Year Contest Winners Online and in the January Issue of Good Housekeeping 3Health News:Weight Watchers(R) Reveals the 2008 Inspiring Stories of the Year Contest Winners Online and in the January Issue of Good Housekeeping 4Health News:Weight Watchers(R) Reveals the 2008 Inspiring Stories of the Year Contest Winners Online and in the January Issue of Good Housekeeping 5Health News:Weight Watchers(R) Reveals the 2008 Inspiring Stories of the Year Contest Winners Online and in the January Issue of Good Housekeeping 6Health News:SAP Provides Prescription for Success to MetroSouth Medical Center 2Health News:SAP Provides Prescription for Success to MetroSouth Medical Center 3Health News:SAP Provides Prescription for Success to MetroSouth Medical Center 4Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 2Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 3Health News:Allscripts Electronic Health Record Ranked No. 1 by Physician Groups in KLAS Year-End Report 4
... make us a leader in this field. With standard ass...laboratory, our Infectious Disease ELISA products ...stency. Our Infectious Disease ELISA menu includes...ological assays including ToRCH, EBV, H. pylori an...
C. Diff-CHEK-30
TOX A/B QUIK CHEK
...e single-well ANA screen and ENA screen ELISAs, as...d 6 individual ENA kits: Sm, Sm/RNP, SS-A (Ro), SS...une ELISA family includes a full line of products ...hyroid Microsomal, MPO, PR3, Rheumatoid Factor and...
Medicine Products: